Durvalumab Side Effects
Medically reviewed by Drugs.com. Last updated on Nov 5, 2023.
Applies to durvalumab: intravenous solution.
Precautions
It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly. Blood and urine tests may be needed to check for unwanted effects.
Receiving this medicine while you are pregnant can harm your unborn baby. If you are a woman who can get pregnant, your doctor may do tests to make sure you are not pregnant before receiving this medicine. Use an effective form of birth control to keep from getting pregnant during treatment with this medicine and for at least 3 months after the last dose. If you think you have become pregnant while receiving the medicine, tell your doctor right away.
Tell your doctor right away if you have a cough, chest tightness, or any type of breathing problem with this medicine. These could be symptoms of a serious lung problem (eg, pneumonitis).
Check with your doctor right away if you have pain or tenderness in the upper stomach, pale stools, dark urine, a loss of appetite, nausea, unusual tiredness or weakness, or yellow eyes or skin. These could be symptoms of a serious liver problem.
Colitis (inflammation of the colon) may occur with this medicine. Tell your doctor right away if you have stomach pain or tenderness, watery or bloody diarrhea, or a fever after receiving the medicine.
Adrenal, pituitary, or thyroid gland problems may occur while you are receiving this medicine. Tell your doctor if you have changes in mood or behavior, constipation, dry skin or hair, feeling cold, sensitivity to heat, sweating, trouble sleeping, or weight changes.
Check with your doctor right away if you have bloody urine, a decrease in frequency or amount of urine, an increase in blood pressure, increased thirst, loss of appetite, lower back or side pain, nausea, swelling of the face, fingers, or lower legs, trouble breathing, unusual tiredness or weakness, vomiting, or weight gain. These could be symptoms of a serious kidney problem.
Serious skin reactions (eg, exfoliative dermatitis, Stevens-Johnson syndrome, drug rash with eosinophilia and systemic syndrome (DRESS), or toxic epidermal necrolysis) can occur with this medicine. Check with your doctor right away if you have blistering, peeling, or loosening of the skin, chills, cough, diarrhea, itching, joint or muscle pain, red irritated eyes, red skin lesions, often with a purple center, severe acne or a skin rash, sore throat, sores or ulcers on the skin, mouth, or lips, swollen glands, unusual bleeding or bruising, or unusual tiredness or weakness with this medicine.
Check with your doctor right away if you have severe headache, drowsiness, confusion, general feeling of illness, or stiff neck or back while you are receiving this medicine. These may be symptoms of meningitis.
Call your doctor right away if you start to have a cough that won't go away, weight loss, night sweats, fever, chills, painful or difficult urination, or flu-like symptoms, such as a runny or stuffy nose, headache, blurred vision, or feeling generally ill. These may be signs that you have an infection.
This medicine may cause inflammation of the heart muscle (myocardium) called myocarditis. Check with your doctor right away if you have chest pain or discomfort, fever, chills, a fast heartbeat, or trouble breathing.
This medicine may cause thrombocytopenic purpura. Check with your doctor right away if you have black, tarry stools, blood in the urine, bloody nose, fever, heavier menstrual periods, pinpoint red spots on the skin, skin rash, unusual bleeding or bruising or unusual tiredness or weakness.
Call your doctor right away if you have difficulty with breathing, swallowing, or talking, muscle weakness, severe tiredness, or sudden numbness and weakness in the arms or legs. These could be symptoms of a nervous system problem.
This medicine may cause a rare but serious type of an allergic reaction called an infusion reaction. This can be life-threatening and requires immediate medical attention. Tell your doctor right away if you start to have a skin rash, dizziness, trouble breathing, chest tightness, swelling in your face or hands, fever or chills while you are receiving this medicine.
This medicine may increase your risk for possible organ transplant rejection. Talk to your doctor about this risk.
Serious side effects of durvalumab
Along with its needed effects, durvalumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking durvalumab:
More common side effects
- bladder pain
- bloating or swelling of the face, arms, hands, lower legs, or feet
- bloody or cloudy urine
- body aches or pain
- chest pain or tightness
- chills
- cough
- depressed mood
- difficult, burning, or painful urination
- difficulty having a bowel movement
- dry skin and hair
- ear congestion
- feeling cold
- fever
- frequent urge to urinate
- general feeling of discomfort or illness
- headache
- hoarseness, husky, or loss of voice
- lower back or side pain
- muscle cramps and stiffness
- nervousness
- runny or stuffy nose
- sensitivity to heat
- slowed heartbeat
- sneezing
- sore throat
- stomach cramps
- sweating
- tenderness
- thickening of bronchial secretions
- tingling of the hands or feet
- trouble breathing
- trouble sleeping
- unusual tiredness or weakness
- unusual weight gain or loss
- watery or bloody diarrhea
Less common side effects
- back, leg, or stomach pains
- black, tarry stools
- bleeding gums
- bloody nose
- blurred vision or other changes in vision
- dark urine
- eye redness, irritation, or pain
- general body swelling
- heavier menstrual periods
- light-colored stools
- loss of appetite
- nausea
- nosebleeds
- pale skin
- pinpoint red spots on the skin
- sensitivity of the eye to light
- skin rash
- stiff neck or back
- tearing
- unusual bleeding or bruising
- upper right abdominal or stomach pain
- vomiting
- yellow eyes and skin
Rare side effects
- blistering, peeling, or loosening of the skin
- dizziness
- drowsiness
- fainting
- joint or muscle pain
- red skin lesions, often with a purple center
- sores, ulcers, or white spots in the mouth or on the lips
- swollen glands
Other side effects of durvalumab
Some side effects of durvalumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- constipation
- lack or loss of strength
- loss or thinning of the hair
For healthcare professionals
Applies to durvalumab: intravenous solution.
Endocrine adverse events
- Common (1% to 10%): Immune-mediated endocrinopathies (e.g., hypothyroidism, hyperthyroidism, adrenal insufficiency, type 1 diabetes mellitus, hypophysitis/hypopituitarism)[Ref]
Dermatologic
- Very common (10% or more): Rash (dermatitis, dermatitis acneiform, dermatitis psoriasiform, psoriasis, rash maculopapular, rash pruritic, rash papular, rash pustular, skin toxicity, eczema, erythema, erythema multiforme, rash erythematous, acne, lichen planus) (11%)[Ref]
Cardiovascular
- Uncommon (0.1% to 1%): Immune-related myocarditis[Ref]
Hematologic
- Very common (10% or more): Lymphopenia (11%)
- Common (1% to 10%): Anemia[Ref]
Genitourinary
- Very common (10% or more): Urinary tract infection (e.g., cystitis, candiduria, urosepsis) (15%)[Ref]
Gastrointestinal
- Very common (10% or more): Constipation (21%), nausea (16%), abdominal pain (upper, lower, flank) (14%), diarrhea/colitis (13%)
- Common (1% to 10%): Dehydration
- Frequency not reported: Immune-mediated colitis[Ref]
Hepatic
- Common (1% to 10%): Liver injury, immune-mediated hepatitis
- Uncommon (0.1% to 1%): Increased ASO, increased ALT, hyperbilirubinemia
- Frequency not reported: Immune-mediated hepatitis[Ref]
Metabolic
- Very common (10% or more): Decreased appetite/hypophagia (19%), hyponatremia (12%)
- Common (1% to 10%): Deterioration of general physical health, increased alkaline phosphatase, hypermagnesemia, hypercalcemia, hyperglycemia, neutropenia, hyperkalemia, hypoalbuminemia[Ref]
Local
- Common (1% to 10%): Infusion-related reactions[Ref]
Immunologic
- Common (1% to 10%): Infections (e.g., sepsis, necrotizing fasciitis, osteomyelitis)[Ref]
Ocular
- Uncommon (0.1% to 1%): Uveitis and keratitis[Ref]
Musculoskeletal
- Very common (10% or more): Musculoskeletal pain (e.g., back pain, musculoskeletal chest pain, musculoskeletal pain and discomfort, myalgia, neck pain) (24%)[Ref]
Nervous system
- Common (1% to 10%): Pyrexia/tumor associated fever
- Uncommon (0.1% to 1%): Immune-related aseptic meningitis[Ref]
Other
- Very common (10% or more): Fatigue (e.g., asthenia, lethargy, malaise) (39%), peripheral edema (e.g., edema, localized edema, edema peripheral, lymphedema, peripheral swelling, scrotal edema, scrotal swelling) (15%), pyrexia/tumor associated fever (14%)
- Common (1% to 10%): Embryofetal toxicity[Ref]
Renal
- Common (1% to 10%): Acute kidney injury, increased creatinine[Ref]
Respiratory
- Very common (10% or more): Dyspnea/exertional dyspnea (24%), cough/productive cough (10%)
- Uncommon (0.1% to 1%): Immune-mediated pneumonitis[Ref]
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Cisplatin
Cisplatin systemic is used for anal cancer, bladder cancer, blood cell transplantation, bone marrow ...
Pembrolizumab
Pembrolizumab (Keytruda) is a monoclonal antibody cancer medicine used to treat
Medroxyprogesterone
Medroxyprogesterone (Provera) treats conditions such as absent or irregular menstrual periods, or ...
Methotrexate
Methotrexate is used to treat certain types of cancer of the breast, skin, head and neck, or lung ...
References
1. (2017) "Product Information. Imfinzi (durvalumab)." Astra-Zeneca Pharmaceuticals
Frequently asked questions
More about durvalumab
- Check interactions
- Compare alternatives
- Reviews (7)
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Durvalumab side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.